ReviewGenes and immunity2026
Immunogenetics in psoriasis: towards personalised diagnosis and treatment strategies.
Review in Genes and immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Genistein in autoimmune diseases: from experimental evidence to emerging clinical data.Frontiers in immunology · 2026Review
- A systems-oriented Ayurvedic approach in chronic plaque psoriasis with renal inflammatory indicators: a 2-year longitudinal case report.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Psoriasis is an autoimmune disorder, and about 125 million people worldwide suffer from this chronic skin disease. It is a multifactorial disorder influenced by the combined action of many genetic factors and their interactions with environmental factors. Recently, significant advances in research have provided greater insight into the pathophysiologic mechanisms, highlighting the roles of genetic susceptibility loci such as HLA-C*06:02, IL12B, and TNIP1, as well as immune pathways involving IL-17, IL-23, and TNF-α. These discoveries not only provided a better understanding of psoriasis but also played a vital role in developing treatment strategies. This review highlights immunological and genetic insights of psoriasis, emphasising their translational relevance. The review also covers how genetic variations modulate the immune response, leading to disease occurrence and chronicity. Moreover, the article explores how these findings are shaping personalised diagnosis and treatment strategies. This strategy holds the promise of enhancing the treatment of individuals with psoriasis by transitioning from the traditional care paradigm to patient-centred care in dermatology.
Indexed as
Identifiers
42129483What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.